Conference Reports for NATAP

Back

4th International Workshop on Hepatitis C Resistance and New Compounds 25-26 June 2009, Boston, MA USA     Analysis of antiviral resistance to MK-7009 in protocol 004, a phase 1b monotherapy study - (12/09/09)   New HCV Drugs, Special Population (Coinfectio) Access: 4th International Workshop on Hepatitis C, Resistance and New Compounds 25-26 June 2009, Boston, MA U - (06/30/09)   FDA Loosens Up HCV Drug Development - HCV Boston Meeting June 27, 2009 - (06/30/09)